Open original FDA record ↗Recall record
- FDA identifier
- Z-1274-2024
- Company in FDA record
- Smiths Medical ASD Inc.
- FDA classification date
- Mar 19, 2024
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class I
Reason stated in the source
When a paraPAC plus ventilator is switched to the operating mode of VENTILATE, the ventilator may intermittently provide continuous positive gas flow instead of the intended cycling like a human breath. This non-cycling and continuous positive gas flow when in the cycling mode, is a malfunction, not allowing the ventilator to properly function as designed.
Source facts
- Action
- Smiths medical issued an "URGENT MEDICAL DEVICE CORRECTION" notice to its consignees on 02/07/2024 via letter using traceable means. The notice explained the issue with the device, potential risk to the patient, and requested the following actions be taken: "There is no need to return or discontinue using your paraPAC plus, at this time. When using the device, all instructions, including warnings and cautions in the User Manual Doc. numbers (10018833-003 and/or 10026347-002) must be followed with heightened awareness. This is inclusive, but not limited to the following: " Constant monitoring of the patient. " Blood oxygenation and expired carbon dioxide levels should be monitored independently using pulse oximetry and capnography. " All pre-use checks must be performed before each use. " Alternative means of ventilation such as bag mask ventilation, must be available in the event of ventilator failure or malfunction. If the paraPac plus ventilator experiences continuous flow, remove the ventilator from clinical use, set the device aside for repair and use another device or alternative means of ventilation." " Customer Required Actions: 1. Please identify all paraPAC plusTM units in your possession. 2. Share this recall notification with all potential users of the devices and if the devices are used at another location. 3. Complete and return the attached Customer Response Form to smithsmedical3488@sedgwick.com. 4. DISTRIBUTORS: If you have distributed potentially affected products to your customers, please immediately forward this notice to them. Request that they complete the response form and return it to smithsmedical3488@sedgwick.com." For questions about this Field Correction Notice, contact your sales representative or call 763-383-3072.
- Initiated
- 2024-02-07
- Root cause
- Under Investigation by firm
- Distribution
- Worldwide distribution: US (nationwide) and OUS countries of: Algeria, Armenia, Australia, Austria, Bangladesh, Bahrain, Bolivia, Plurinational state of, Brazil, Bulgaria, Canada, Colombia, Czech Republic, Cyprus, Ecuador, Egypt, El Salvador, Estonia, France, Germany, Greece, Hong Kong, Iceland, India, Indonesia, Israel, Ireland, Italy, Japan, Jordan, Kuwait, Lebanon, Libya, Malaysia, Mexico, Netherlands, New Zealand, Norway, Oman, Pakistan, Panama, Philippines, Poland, Portugal, Qatar, Romania, Singapore, Slovakia, Slovenia, Saudi Arabia, South Africa, Spain, Sweden, Tawain, Province of China, Thailand, Trinidad and Tobago, Turkey, United Kingdom and Viet Nam.
- Recall number
- Z-1274-2024
- Recall status
- Open, Classified
- CDRH record ID
- 206298
- FDA classified
- 2024-03-19
- Recall event number
- 94089